
Sign up to save your podcasts
Or


Send a text
Co-Founder, President & CEO of Aro Biotherapeutics Sue Dillon, PhD, joins Chris and Rachael to discuss her transition from pharma executive to start-up founder. Sue discusses her experience building a network of investors outside of pharmaceuticals, curating a team, leadership accountabilities, and more.
Submit questions to future guests to [email protected].
By Life Sciences PennsylvaniaSend a text
Co-Founder, President & CEO of Aro Biotherapeutics Sue Dillon, PhD, joins Chris and Rachael to discuss her transition from pharma executive to start-up founder. Sue discusses her experience building a network of investors outside of pharmaceuticals, curating a team, leadership accountabilities, and more.
Submit questions to future guests to [email protected].